Observational studyClinical and translational gastroenterology2020

Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.

Felix Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.